Skip to main content

Table 2 ICU-specific antimicrobial consumption in DDDs, KAMC-R,2012–2015

From: Antimicrobial consumption in five adult intensive care units: a 33-month surveillance study

  Medical/ surgical Neuro-surgical Burn Cardio-thoracic Step-down Total
Number of DDDs
 Aminoglycosides 449.0 161.4 84.3 24.6 350.2 1069.5
 Carbapenems 6890.1 1886.4 1102.5 772.0 3198.6 13,849.5
 Cephalosporins 1278.8 610.2 158.3 52.2 476.7 2576.1
 Fluoroquinolones 1822.0 635.0 376.5 395.4 1306.8 4535.6
 Piperacillin/Tazobactam 3044.2 1528.0 605.8 929.9 1162.4 7270.2
 Vancomycin 2362.2 1030.5 513.4 388.0 1018.1 5312.2
 Tigecycline 562.5 8.5 324.0 52.5 308.0 1255.5
 Colistin 305.6 93.5 138.1 21.4 179.8 738.3
 Caspofungin 2572.7 195.4 179.0 187.4 991.0 4125.5
 Amphotericin B 1694.9 137.1 150.9 0.0 1254.7 3237.6
 Total 20,981.9 6285.9 3632.7 2823.4 10,246.3 43,970.1
Denominator
 Patient days 19,105 7288 6759 7105 13,859 54,116
 Admissions 1620 786 391 1499 623 4919
 Average length of stay 11.8 9.3 17.3 4.7 22.2 11.0
Rates per 1000 patient-days
 Aminoglycosides 23.5 22.1 12.5 3.5 25.3 19.8
 Carbapenems 360.6 258.8 163.1 108.7 230.8 255.9
 Cephalosporins 66.9 83.7 23.4 7.4 34.4 47.6
 Fluoroquinolones 95.4 87.1 55.7 55.7 94.3 83.8
 Piperacillin/Tazobactam 159.3 209.7 89.6 130.9 83.9 134.3
 Vancomycin 123.6 141.4 76.0 54.6 73.5 98.2
 Tigecycline 29.4 1.2 47.9 7.4 22.2 23.2
 Colistin 16.0 12.8 20.4 3.0 13.0 13.6
 Caspofungin 134.7 26.8 26.5 26.4 71.5 76.2
 Amphotericin B 88.7 18.8 22.3 0.0 90.5 59.8
 Total 1098.2 862.5 537.5 397.4 739.3 812.5